Recombinant Antibody Engineering and Production
Using Leinco’s Proprietary HEK293 and CHO Transgene Expression Systems
Leinco Technologies offers a panel of services to scientists looking for recombinant monoclonal antibody production at the highest purity. These are available for conducting early discovery and preclinical research. Preclinical research is an essential and initial step for understanding the complexity and mechanisms of disease. Furthermore, these studies allow scientists and clinicians to create models of disease states and reveal the biochemical and cellular processes responsible for the development of diseases. As the precursors and courses of action of the disease are discovered, preclinical research is directed toward investigating the safety and efficacy of treatment theories.